RBC NOS: regulatory mechanisms and therapeutic aspects

Ignarro, 1990, Biosynthesis and metabolism of endothelium-derived nitric oxide, Annu. Rev. Pharmacol. Toxicol., 30, 535, 10.1146/annurev.pa.30.040190.002535 Rassaf, 2002, Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood, Circ. Res., 91, 470, 10.1161/01.RES.0000035038.41739.CB Bryan, 2004, Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo, Proc. Natl. Acad. Sci. U. S. A., 101, 4308, 10.1073/pnas.0306706101 Moncada, 1993, The l-arginine-nitric oxide pathway, N. Engl. J. Med., 329, 2002, 10.1056/NEJM199312303292706 Govers, 2001, Cellular regulation of endothelial nitric oxide synthase, Am. J. Physiol. Renal Physiol., 280, F193, 10.1152/ajprenal.2001.280.2.F193 Crane, 1997, The structure of nitric oxide synthase oxygenase domain and inhibitor complexes, Science, 278, 425, 10.1126/science.278.5337.425 Nathan, 1997, Inducible nitric oxide synthase: what difference does it make?, J. Clin. Invest., 100, 2417, 10.1172/JCI119782 Liu, 1996, Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization, Biochemistry, 35, 13277, 10.1021/bi961720e Feron, 1998, The endothelial nitric-oxide synthase-caveolin regulatory cycle, J. Biol. Chem., 273, 3125, 10.1074/jbc.273.6.3125 Tripatara, 2007, Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase, J. Am. Soc. Nephrol., 18, 570, 10.1681/ASN.2006050450 Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224 Fulton, 1999, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, 399, 597, 10.1038/21218 Leiper, 2007, Disruption of methylarginine metabolism impairs vascular homeostasis, Nat. Med., 13, 198, 10.1038/nm1543 McDonald, 1997, A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the ‘arginine paradox’, J. Biol. Chem., 272, 31213, 10.1074/jbc.272.50.31213 Dedio, 2001, NOSIP, a novel modulator of endothelial nitric oxide synthase activity, FASEB J., 15, 79, 10.1096/fj.00-0078com Zimmermann, 2002, NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. U. S. A., 99, 17167, 10.1073/pnas.252345399 Erwin, 2005, Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells, J. Biol. Chem., 280, 19888, 10.1074/jbc.M413058200 Martínez-Ruiz, 2005, S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities, Proc. Natl. Acad. Sci. U. S. A., 102, 8525, 10.1073/pnas.0407294102 Yasukawa, 2005, S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance, J. Biol. Chem., 280, 7511, 10.1074/jbc.M411871200 Santhanam, 2007, Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction, Circ. Res., 101, 692, 10.1161/CIRCRESAHA.107.157727 Leiper, 2002, S-nitosrylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase, Proc. Natl. Acad. Sci. U. S. A., 99, 13527, 10.1073/pnas.212269799 Vanin, 2007, Nitric oxide synthase reduces nitrite to NO under anoxia, Cell. Mol. Life Sci., 64, 96, 10.1007/s00018-006-6374-2 Kleinbongard, 2006, Red blood cells express a functional endothelial nitric oxide synthase, Blood, 107, 2943, 10.1182/blood-2005-10-3992 Bratosin, 2001, Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria, Cell Death Differ., 8, 1143, 10.1038/sj.cdd.4400946 Kleinbongard, 2007, New functional aspects of the l-arginine-nitric oxide metabolism within the circulating blood, Thromb. Haemost., 98, 970, 10.1160/TH07-04-0305 Jiang, 2006, Arginase-flotillin interaction brings arginase to red blood cell membrane, FEBS Lett., 580, 6561, 10.1016/j.febslet.2006.11.003 Wang, 1999, Regression of atherosclerosis. Role of nitric oxide and apoptosis, Circulation, 99, 1236, 10.1161/01.CIR.99.9.1236 Schnorr, 2008, Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo, Arch. Biochem. Biophys., 10.1016/j.abb.2008.02.040 Kilberg, 1993, Recent advances in mammalian amino acid transport, Annu. Rev. Nutr., 13, 137, 10.1146/annurev.nu.13.070193.001033 Shima, 2006, l-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes, Blood, 107, 1352, 10.1182/blood-2005-08-3166 Harrison, 1968, The calcium content of human erythrocytes, J. Physiol., 199, 367, 10.1113/jphysiol.1968.sp008658 Allan, 1980, The isolation and characterization of 60nm vesicles (‘nanovesicles’) produced during ionophore A23187-induced budding of human erythrocytes, Biochem. J., 188, 881, 10.1042/bj1880881 Iida, 1991, Membrane vesiculation protects erythrocytes from destruction by complement, J. Immunol., 147, 2638, 10.4049/jimmunol.147.8.2638 Anderson, 1977, Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease, J. Biol. Chem., 252, 6617, 10.1016/S0021-9258(17)39892-7 Allan, 1981, Ca2+-induced biochemical changes in human erythrocytes and their relation to microvesiculation, Biochem. J., 198, 433, 10.1042/bj1980433 Schatzmann, 1983, The red cell calcium pump, Annu. Rev. Physiol., 45, 303, 10.1146/annurev.ph.45.030183.001511 Nash, 1983, Red cell and ghost viscoelasticity. Effects of hemoglobin concentration and in vivo aging, Biophys. J., 43, 63, 10.1016/S0006-3495(83)84324-0 Monzon, 1982, Erythrocytic calmodulin correlates with red cell age, Br. J. Haematol., 51, 261, 10.1111/j.1365-2141.1982.tb02779.x Mesquita, 2001, Effects of acetylcholine and spermineNONOate on erythrocyte hemorheologic and oxygen carrying properties, Clin. Hemorheol. Microcirc., 25, 153 Carvalho, 2004, Acetylcholine and choline effects on erythrocyte nitrite and nitrate levels, J. Appl. Toxicol., 24, 419, 10.1002/jat.993 Kelm, 1990, Control of coronary vascular tone by nitric oxide, Circ. Res., 66, 1561, 10.1161/01.RES.66.6.1561 Kawashima, 1998, Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes, Life Sci., 62, 1701, 10.1016/S0024-3205(98)00131-3 Tang, 1991, Human erythrocyte as a model for investigating muscarinic agonists and antagonists, Gen. Pharmacol., 22, 485, 10.1016/0306-3623(91)90010-4 Huestis, 1974, A functional acetylcholine receptor in the human erythrocyte, Biochem. Biophys. Res. Commun., 57, 726, 10.1016/0006-291X(74)90606-8 Brown, 1998, Functions of lipid rafts in biological membranes, Annu. Rev. Cell Dev. Biol., 14, 111, 10.1146/annurev.cellbio.14.1.111 Salzer, 2001, Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts, Blood, 97, 1141, 10.1182/blood.V97.4.1141 Morrow, 2002, Flotillin-1/reggie-2 traffics to surface raft domains via a novel Golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation, J. Biol. Chem., 277, 48834, 10.1074/jbc.M209082200 Neumann-Giesen, 2004, Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression, Biochem. J., 378, 509, 10.1042/bj20031100 Langhorst, 2005, Scaffolding microdomains and beyond: the function of reggie/flotillin proteins, Cell. Mol. Life Sci., 62, 2228, 10.1007/s00018-005-5166-4 Stewart, 1992, Isolation of cDNA coding for an ubiquitous membrane protein deficient in high Na+, low K+ stomatocytic erythrocytes, Blood, 79, 1593, 10.1182/blood.V79.6.1593.1593 Hoeflich, 2002, Calmodulin in action: diversity in target recognition and activation mechanisms, Cell, 108, 739, 10.1016/S0092-8674(02)00682-7 Jarrett, 1977, Partial purification of the Ca2+-Mg2+ ATPase activator from human erythrocytes: its similarity to the activator of 3′:5′-cyclic nucleotide phosphodiesterase, Biochem. Biophys. Res. Commun., 77, 1210, 10.1016/S0006-291X(77)80108-3 Anderson, 1987, The interaction of calmodulin with human erythrocyte spectrin. Inhibition of protein 4.1-stimulated actin binding, J. Biol. Chem., 262, 6365, 10.1016/S0021-9258(18)45579-2 Coleman, 1987, Beta spectrin bestows protein 4.1 sensitivity on spectrin-actin interactions, J. Cell Biol., 104, 519, 10.1083/jcb.104.3.519 Mische, 1987, Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding, J. Cell Biol., 105, 2837, 10.1083/jcb.105.6.2837 Ellis, 1987, Proteins as molecular chaperones, Nature, 328, 378, 10.1038/328378a0 Gromov, 1991, Identification of two molecular chaperons (HSX70, HSC70) in mature human erythrocytes, Exp. Cell Res., 195, 556, 10.1016/0014-4827(91)90412-N Jia, 1996, S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control, Nature, 380, 221, 10.1038/380221a0 Stamler, 1997, Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient, Science, 276, 2034, 10.1126/science.276.5321.2034 McMahon, 2000, Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin, J. Biol. Chem., 275, 16738, 10.1074/jbc.M000532200 Huang, 2001, Modulation of nitric oxide bioavailability by erythrocytes, Proc. Natl. Acad. Sci. U. S. A., 98, 11771, 10.1073/pnas.201276698 Pawloski, 2001, Export by red blood cells of nitric oxide bioactivity, Nature, 409, 622, 10.1038/35054560 Wennmalm, 1992, Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin, Br. J. Pharmacol., 106, 507, 10.1111/j.1476-5381.1992.tb14365.x Gow, 1999, The oxyhemoglobin reaction of nitric oxide, Proc. Natl. Acad. Sci. U. S. A., 96, 9027, 10.1073/pnas.96.16.9027 Gladwin, 2005, Nitrite as an intrinsic signaling molecule, Nat. Chem. Biol., 1, 245, 10.1038/nchembio1005-245 McMahon, 2002, Nitric oxide in the human respiratory cycle, Nat. Med., 8, 711, 10.1038/nm718 Doctor, 2005, Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients, Proc. Natl. Acad. Sci. U. S. A., 102, 5709, 10.1073/pnas.0407490102 Lipton, 2001, S-Nitrosothiols signal the ventilatory response to hypoxia, Nature, 413, 171, 10.1038/35093117 Palmer, 2007, S-Nitrosothiols signal hypoxia-mimetic vascular pathology, J. Clin. Invest., 117, 2592, 10.1172/JCI29444 Herold, 2001, Kinetic and mechanistic studies of the reactions of nitrogen monoxide and nitrite with ferryl myoglobin, J. Biol. Inorg. Chem., 6, 543, 10.1007/s007750100231 Gibson, 1957, The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin, J. Physiol., 136, 507, 10.1113/jphysiol.1957.sp005777 Liu, 1998, Diffusion-limited reaction of free nitric oxide with erythrocytes, J. Biol. Chem., 273, 18709, 10.1074/jbc.273.30.18709 Vaughn, 1998, Effective diffusion distance of nitric oxide in the microcirculation, Am. J. Physiol., 274, H1705 Liao, 1999, Intravascular flow decreases erythrocyte consumption of nitric oxide, Proc. Natl. Acad. Sci. U. S. A., 96, 8757, 10.1073/pnas.96.15.8757 Vaughn, 2000, Erythrocytes possess an intrinsic barrier to nitric oxide consumption, J. Biol. Chem., 275, 2342, 10.1074/jbc.275.4.2342 Rogers, 2005, Detection of human haemoglobin-bound nitric oxide, J. Biol. Chem., 280, 26720, 10.1074/jbc.M501179200 Nagababu, 2003, Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction, J. Biol. Chem., 278, 46349, 10.1074/jbc.M307572200 Patel, 1999, Biochemical characterization of human S-nirosohemoglobin, J. Biol. Chem., 274, 15487, 10.1074/jbc.274.22.15487 Pawloski, 1998, Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation, Circulation, 97, 263, 10.1161/01.CIR.97.3.263 Lundberg, 2008, The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics, Nat. Rev. Drug Discov., 7, 156, 10.1038/nrd2466 McMahon, 2005, A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension, Proc. Natl. Acad. Sci. U. S. A., 102, 14801, 10.1073/pnas.0506957102 Pawloski, 2005, Impaired vasodilation by red blood cells in sickle cell disease, Proc. Natl. Acad. Sci. U. S. A., 102, 2531, 10.1073/pnas.0409876102 Ellsworth, 1995, The erythrocyte as a regulator of vascular tone, Am. J. Physiol., 269, H2155 Gonzalez-Alonso, 2002, Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP, Circ. Res., 91, 1046, 10.1161/01.RES.0000044939.73286.E2 Chen, 1998, Evidence for the presence of l-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function, J. Cardiovasc. Pharmacol., 32, 57, 10.1097/00005344-199807000-00009 Deliconstantinos, 1995, Nitric oxide and peroxynitrite production by human erythrocytes: a causative factor of toxic anemia in breast cancer patients, Anticancer Res., 15, 1435 Jubelin, 1996, Erythrocytes may synthesize their own nitric oxide, Am. J. Hypertens., 9, 1214, 10.1016/S0895-7061(96)00257-9 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med., 352, 1685, 10.1056/NEJMra043430 Heiss, 2006, Plasma nitroso compounds are decreased in patients with endothelial dysfunction, J. Am. Coll. Cardiol., 47, 573, 10.1016/j.jacc.2005.06.089 Berliner, 2005, Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease, Am. Heart J., 149, 260, 10.1016/j.ahj.2004.05.058 Anuk, 2002, Prognostic implications of admission inflammatory profile in acute ischemic neurological events, Acta Neurol. Scand., 106, 196, 10.1034/j.1600-0404.2002.01224.x Muda, 2003, Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients, J. Hypertens., 21, 2329, 10.1097/00004872-200312000-00022 Blankenberg, 2003, Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease, N. Engl. J. Med., 349, 1605, 10.1056/NEJMoa030535 Laufs, 1998, Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors, Circulation, 97, 1129, 10.1161/01.CIR.97.12.1129 Merx, 2005, Statin treatment after onset of sepsis in a murine model improves survival, Circulation, 112, 117, 10.1161/CIRCULATIONAHA.104.502195 Ludolph, 2007, Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity, Vasc. Health Risk Manag., 3, 1069 Bor-Kucukatay, 2003, Effects of nitric oxide on red blood cell deformability, Am. J. Physiol. Heart Circ. Physiol., 284, H1577, 10.1152/ajpheart.00665.2002 Starzyk, 1999, Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro, J. Physiol. Pharmacol., 50, 629 Merx, 2007, Myocardial reperfusion injury and the challenging quest for its prevention, Crit. Care Med., 35, 1793, 10.1097/01.CCM.0000269355.63009.C1 Lee, 2004, Anemia is an independent predictor of mortality after percutaneous coronary intervention, J. Am. Coll. Cardiol., 44, 541, 10.1016/j.jacc.2004.04.047 Lipsic, 2006, Protective effects of erythropoietin in cardiac ischemia: from bench to bedside, J. Am. Coll. Cardiol., 48, 2161, 10.1016/j.jacc.2006.08.031 Sailaja, 2003, The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics, Free Radic. Biol. Med., 35, 133, 10.1016/S0891-5849(03)00071-6 Wu, 2001, Blood transfusion in elderly patients with acute myocardial infarction, N. Engl. J. Med., 345, 1230, 10.1056/NEJMoa010615 de Franceschi, 2003, Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation, Blood, 102, 1087, 10.1182/blood-2002-07-2135 Reiter, 2002, Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease, Nat. Med., 8, 1383, 10.1038/nm1202-799 Weiner, 2003, Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease, JAMA, 289, 1136, 10.1001/jama.289.9.1136 Erzurum, 2007, Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans, Proc. Natl. Acad. Sci. U. S. A., 104, 17593, 10.1073/pnas.0707462104 Ruschitzka, 2000, Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin, Proc. Natl. Acad. Sci. U. S. A., 97, 11609, 10.1073/pnas.97.21.11609 Bennett-Guerrero, 2007, Evolution of adverse changes in stored RBCs, Proc. Natl. Acad. Sci. U. S. A., 104, 17063, 10.1073/pnas.0708160104 Reynolds, 2007, S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood, Proc. Natl. Acad. Sci. U. S. A., 104, 17058, 10.1073/pnas.0707958104 Harrison, 1997, Cellular and molecular mechanisms of endothelial cell dysfunction, J. Clin. Invest., 100, 2153, 10.1172/JCI119751 Martinez-Ruiz, 2004, S-nitrosylation: a potential new paradigm in signal transduction, Cardiovasc. Res., 62, 43, 10.1016/j.cardiores.2004.01.013